Dr. Michael Theodoulides is a distinguished researcher with a Ph.D. in Medicine and Engineering, specializing in Nanotoxicology, from Swansea University Medical School. His doctoral work focused on exploring the genotoxic and cytotoxic effects of metal oxide nanoparticles under physiologically relevant conditions. He also holds a first-class BSc (Hons) in Applied Biological Sciences from the University of Wolverhampton, where his dissertation explored novel therapeutic approaches for dystrophinopathies.
Dr. Theodoulides has a diverse professional background that spans both academia and industry. He has held roles such as R&D Program Manager, Technical Proposal Writer, and Postdoctoral Fellow. His contributions include developing technical proposals, leading multidisciplinary research projects, supervising postgraduate students, and fostering collaborations in fields like nanotechnology and biomedical sciences.
An accomplished scientist, Dr. Theodoulides has published peer-reviewed articles, presented his findings at international conferences, and received prestigious academic scholarships and awards. Currently, he is driving innovative R&D initiatives as a key contributor at RTD Talos. His expertise encompasses nanotoxicology, data analysis, project management, and science communication, making him a valued leader in multidisciplinary research and development.
- mt@talos-rtd.com
